ULCERATIVE COLITIS CHRONIC
Clinical trials for ULCERATIVE COLITIS CHRONIC explained in plain language.
Never miss a new study
Get alerted when new ULCERATIVE COLITIS CHRONIC trials appear
Sign up with your email to follow new studies for ULCERATIVE COLITIS CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a probiotic tame ulcerative colitis? early trial begins
Disease control Recruiting nowThis early-stage study is testing whether an oral probiotic called R-3750 is safe and tolerable for people with mild to moderate ulcerative colitis. About 36 adults will take the probiotic and be monitored for side effects, inflammation, and symptom changes. The goal is to see if…
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated Jun 23, 2026 11:55 UTC
-
New hope for ulcerative colitis: drug combo trial launches
Disease control Recruiting nowThis study tests a new drug called eltrekibart, given alone or with another drug (mirikizumab), in 140 adults with moderate-to-severe ulcerative colitis. The goal is to see if the treatment can reduce symptoms and help the colon heal. Participants must have tried other treatments…
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New hope for kids with IBD: Long-Term drug study launches
Disease control Recruiting nowThis study looks at how well and how safely the drug mirikizumab works over a long period (about 3 years) in children and teenagers with moderate-to-severe ulcerative colitis or Crohn's disease. About 150 participants who have already been in earlier studies will continue treatme…
Matched conditions: ULCERATIVE COLITIS CHRONIC
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 11, 2026 11:57 UTC